PAVmed (PAVM) Amortization of Deferred Charges (2017 - 2018)
PAVmed (PAVM) posted Amortization of Deferred Charges of $505848.0 for Q3 2018, up 65.45% on a QoQ basis from $305734.0 in Q2 2018.
Powered by 
Analysis
PAVmed (PAVM) Amortization of Deferred Charges (2017 - 2018) Analysis & Trends
PAVmed has reported Amortization of Deferred Charges for 2 years, with the latest figure at $505848.0 in Q3 2018.
- On a quarterly basis, Amortization of Deferred Charges changed N/A year-over-year to $505848.0 in Q3 2018; TTM through Sep 2018 was $1.3 million, a N/A change from a year earlier, with the FY2017 full-year figure at $347601.0, changed N/A from the prior year.
- Amortization of Deferred Charges was $505848.0 for Q3 2018 at PAVmed, up from $305734.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $505848.0 in Q3 2018, with the low at $172959.0 in Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn |
| 10 | PAVmed | 123.57 Mn | 104.04 Mn | -89,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 505,848.00 |
| Jun 30, 2018 | 305,734.00 |
| Mar 31, 2018 | 305,733.00 |
| Dec 31, 2017 | 172,959.00 |